DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🔴 Decoy Therapeutics is trading 7.93% down in pre-market — no fresh company-specific catalyst identified
Decoy Therapeutics is trading 7.93% down at $3.02 after falling from the August 20 close of $3.28, with no fresh company-specific catalyst identified. - The...
🟢 Decoy Therapeutics is trading 8.71% up today after successful Phase 3 personalized cancer-vaccine results
Decoy Therapeutics is trading 8.71% up now at $3.71, with the move appearing mainly linked to stronger biotechnology sentiment after Moderna and Merck reported...
🔴 Decoy Therapeutics is trading 5% down today with no clear company-specific catalyst
Decoy Therapeutics is trading $3.48 (-5.18%) lower, with no clear company-specific catalyst identified for August 19, 2026. • Recent Q2 results showed a $2.4...
🔴 Decoy Therapeutics is trading 15.54% down in pre-market without a clear company-specific catalyst
Decoy Therapeutics is trading 15.54% down at $3.10 after no clear company-specific catalyst was identified for August 19, 2026. • Recent Q2 results reported a...
🟢 Decoy Therapeutics is trading 5.4% up today; no clear catalyst identified
Decoy Therapeutics is trading 5.4% up at $3.71, despite broader U.S. markets moving lower on August 18, 2026; the rally’s cause remains unclear. - Searches...
🟢 Decoy Therapeutics is trading 8% up today
Decoy Therapeutics is trading at $3.88, up +8.38%, with no clear catalyst identified. - No new company-specific announcement dated August 17, 2026 was...
Decoy Therapeutics Posts Wider Loss and Warns of Delisting — So Why Is the Stock Up Nearly 9%?
Shares of Decoy Therapeutics (DCOY) shifted higher Thursday, rising 8.8% to $3.84, even as the preclinical-stage biotech disclosed a grim set of second-quarter...
🟢 Decoy Therapeutics is trading 8.8% up in after-hours trading after warning of potential Nasdaq delisting risk
Decoy Therapeutics is trading 8.78% up now at $3.84 after warning its shortened cash runway could create a potential Nasdaq delisting risk. - Reported a $2.37...
Decoy Therapeutics Warns of Potential Delisting, Citing Shortened Cash Runway
Decoy Therapeutics Inc. reported a $2.37 million net loss for the second quarter of 2026. This result represents a significant widening from the previous...
🔴 Decoy Therapeutics is trading 7% down today with no clear catalyst
Decoy Therapeutics is trading 7% down at $3.60, extending recent weakness despite broader U.S. indexes trading higher on August 12, 2026, with the cause...
🟢 Decoy Therapeutics is trading 5.3% up today with no confirmed company-specific catalyst
Decoy Therapeutics is trading 5.3% up at $4.07, with no confirmed company-specific announcement or Q2 earnings release found for August 11, 2026. - The...
Decoy Therapeutics Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Decoy Therapeutics is expected to report a Q2 2026 consensus loss of $2.88 per share on $0 revenue, with the stock currently trading at $3.92, significantly...
🟢 Decoy Therapeutics is trading 5.67% up today in pre-market
Decoy Therapeutics is trading 5.67% up now at $4.29, based on the provided pre-market quote; no clear August 7, 2026 company-specific catalyst was...
🔴 Decoy Therapeutics is trading 6.7% down today on profit-taking after recent gains
Decoy Therapeutics is trading 6.7% down at $4.08 as the stock gives back a portion of its sharp rebound from late-July lows. • There are no fresh...
🔴 Decoy Therapeutics is trading 8.2% down today with no clear catalyst
Decoy Therapeutics is trading 8.2% down at $4.01 today, extending yesterday’s consolidation after a sharp rebound from late-July lows. • There is currently no...
🔴 Decoy Therapeutics is trading 5.5% down today as shares consolidate after a multi-day rebound
Decoy Therapeutics is trading 5.5% down at $4.10 as shares consolidate following a sharp multi-day rebound from its July 27 plunge. • The move comes despite a...
🟢 Decoy Therapeutics is trading 7.79% up today in sentiment-driven rebound
Decoy Therapeutics is trading at $4.43 (+7.79%) in active morning trading, moving higher despite a lack of fresh company-specific news or fundamental...
🟢 Decoy Therapeutics is trading 5.3% up today with no clear catalyst
Decoy Therapeutics is trading at $4.33 (5.3%) up today, rebounding modestly from a sharp pullback on July 27 despite a lack of fundamental news. • The price...
🔴 Decoy Therapeutics is trading 8.6% down today after a sharp overnight selloff
Decoy Therapeutics is trading at $3.76 (-8.59%) in pre-market after a sharp overnight selloff with no clear catalyst identified. • No company-specific news,...
🟢 Decoy Therapeutics is trading 9% up today as Ebola Zaire data-driven rebound continues
Decoy Therapeutics is trading at $4.27 (9% up) in after-hours trading as the stock extends a rebound triggered by positive July 28 lab results for its Ebola...